E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/30/2021 in the Prospect News Bank Loan Daily, Prospect News Convertibles Daily, Prospect News Distressed Debt Daily, Prospect News Emerging Markets Daily, Prospect News Investment Grade Daily and Prospect News Private Placement Daily.

Medline deal leads $9.95 billion Thursday HY primary; LSB, New Enterprise on 101-handle

By Paul A. Harris and Abigail W. Adams

Portland, Me., Sept. 30 – Although high-yield primary market activity in September fell short of expectations, it went out with a bang on Thursday as eight issuers priced $9.95 billion in nine tranches.

The lion's share of it came from Medline Industries which priced a downsized $7 billion two-tranche offering.

Meanwhile, the secondary space was largely unchanged on Thursday as accounts closed the books on the third quarter.

While rising Treasury yields continued to pressure rate-sensitive names, new deals remained in demand with the majority continuing to perform well in the aftermarket.

LSB Industries, Inc.’s 6¼% senior notes due 2028 (B3/B-) and New Enterprise Stone & Lime Co., Inc.’s 5¼% senior secured notes due 2028 (B2/B+) were putting in strong performances with both issues on a 101-handle as investors sought out the higher-yielding notes.

However, Foot Locker, Inc.’s 4% senior notes due 2029 (Ba2/BB+) fell largely flat in the aftermarket, which was attributed to their tight pricing.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.